BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 10321365)

  • 1. The importance of age in screening for cancer.
    Law MR; Morris JK; Wald NJ
    J Med Screen; 1999; 6(1):16-20. PubMed ID: 10321365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
    Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
    Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
    Miser WF
    Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
    [No Abstract]   [Full Text] [Related]  

  • 6. [Screening for cancer. International knowledge and Danish practice].
    Lynge E
    Ugeskr Laeger; 2002 May; 164(22):2892-7. PubMed ID: 12082817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer: incidence and deaths in Canada, 1990.
    Gaudette L; Lee J; Silberberger C
    Health Rep; 1993; 5(4):348-54. PubMed ID: 8011953
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer screening rates in individuals with different life expectancies.
    Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
    JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of cancer in the United States.
    Cresanta JL
    Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of screening in women cancers and in 75 years older in Loire department].
    Swalduz A; Guibert C; Trone JC; Guichard JB; Rivoirard R; Pacaut C; Méry B; Guy JB; Eddekkaoui H; Fournel P; de Laroche G; Merrouche Y; Magné N
    Bull Cancer; 2014 Sep; 101(9):808-12. PubMed ID: 25229392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study.
    Tuesley KM; Jordan SJ; Siskind DJ; Kendall BJ; Kisely S
    Aust N Z J Psychiatry; 2019 Jun; 53(6):550-558. PubMed ID: 30501394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].
    Colonna M; Bossard N; Mitton N; Remontet L; Belot A; Delafosse P; Grosclaude P;
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):434-40. PubMed ID: 19010627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer screening estimates for U.S. metropolitan areas.
    Nelson DE; Bolen J; Marcus S; Wells HE; Meissner H
    Am J Prev Med; 2003 May; 24(4):301-9. PubMed ID: 12726867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When should we stop screening?
    Rich JS; Black WC
    Eff Clin Pract; 2000; 3(2):78-84. PubMed ID: 10915327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening of cancer of the most frequent localizations].
    Belialova NS; Belialov FI
    Klin Med (Mosk); 2005; 83(10):4-9. PubMed ID: 16320836
    [No Abstract]   [Full Text] [Related]  

  • 18. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
    Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a combined screening programme for breast, cervical and colorectal cancers in France.
    Billette de Villemeur A; Exbrayat C; Garnier A; Ancelle-Park R; Ferley JP; Jestin C
    Eur J Cancer Prev; 2007 Feb; 16(1):26-35. PubMed ID: 17220701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.